THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy.

MAP Podcast

Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world.

MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market access , reimbursement and pricing issues in the D-A-CH countries and around the world. With MAP you will get a summary of core market access systems and processes as well as latest changes in regulations including statements and opinions of core decision makers and stakeholders from various countries.

Map Thumbnail 9

Podcast available on:

How important are the famous NUBs, OPS and DRG values? How can innovations reach patients beyond administrative barriers? What are the next steps in terms of digitalization of health care in Germany? Dr. Stefan Walzer and Dr. Sebastian Casu – medical doctor and medical influencer - are continuing the conversation about inpatient market access processes with a strong focus on bed-side innovation including digitalization of healthcare. This episode is linked to episode 9 with Willi Wöllner and the hospital business administration perspective (from January 1 2022). 

 

Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: https://lnkd.in/dZtyKw8B

 

MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de

How does reimbursement work in the German hospital setting and how are hospitals organized doing such negotiations? What is a NUB and how does this relate to annual hospital budget discussions with the health insurance funds? Can industry really take part in this process?

Dr. Stefan Walzer and the experienced hospital adminstrator Willi Wöllner are going deep on inpatient settings from a business perspective. Part II from a medical perspective will follow in the next episode with Dr. Sebastian Casu.

Take the chance to stay connected and subscribe with your favorite podcasting platform.

For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de

Who could be better to tell us the real insights, how the arbitration board works than Prof. Dr. Juergen Wasem, the former head of the AMNOG arbitration board and the current head of the DiGA arbitration board.

In this wide ranging conversation Dr. Stefan Walzer confronted Prof. Wasem with in-depth issues to take the arbitration board as well into strategic considerations.

Take the chance to stay connected and subscribe with your favorite podcasting platform.

For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de